View Item 

Show simple item record

Pranolium

dc.contributor.authorKopia, Gregory A.en_US
dc.contributor.authorEller, Brian T.en_US
dc.contributor.authorPatterson, Eugeneen_US
dc.contributor.authorLucchesi, Benedict Roberten_US
dc.date.accessioned2010-06-01T19:02:14Z
dc.date.available2010-06-01T19:02:14Z
dc.date.issued1983-03en_US
dc.identifier.citationKopia, Gregory A.; Eller, Brian T.; Patterson, Eugene; Lucchesi, Benedict R. (1983). "Pranolium." Cardiovascular Drug Reviews 1(1): 151-201. <http://hdl.handle.net/2027.42/72226>en_US
dc.identifier.issn0897-5957en_US
dc.identifier.issn1527-3466en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72226
dc.format.extent4465218 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1983 Neva Press, Branford, Connecticuten_US
dc.titlePranoliumen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan 48109en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72226/1/j.1527-3466.1983.tb00447.x.pdf
dc.identifier.doi10.1111/j.1527-3466.1983.tb00447.xen_US
dc.identifier.sourceCardiovascular Drug Reviewsen_US
dc.identifier.citedreferenceAhlmank, G., Saetre, H., and Korsgren, M. ( 1974 ): Reduction of sudden deaths after myocardial infarction. Lancet, 2 ( 7896 ): 1563.en_US
dc.identifier.citedreferenceAndersen, M. P., Bechsgaard, P., Frederiksen, J., Hansen, D. A., Jurgensen, H. J., Nielsen, B., Pedersen, F., Pedersen-Bjergaard, O., and Rasmussen, S. L. ( 1979 ): Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Lancet, 2 ( 8148 ): 865 – 868.en_US
dc.identifier.citedreferenceAnderson, J. L., Patterson, E., Conlon, M., Pasyk, S., Pitt, B., and Lucchesi, B. R. ( 1980 ): Kinetics of antifibrillatory effects of bretylium: Correlation with myocardial drug concentration. Am. J. Cardiol., 46: 583 – 592.en_US
dc.identifier.citedreferenceAnderson, J. L., Patterson, E., Wagner, J. G., Stewart, J. R., Behm, H. L., and Lucchesi, B. R. ( 1980 ): Oral and intravenous bretylium disposition. Clin. Pharmacol. Ther., 28: 468 – 478.en_US
dc.identifier.citedreferenceAriens, E. J. ( 1967 ): The structure activity relationships of beta-adrenergic drugs and beta-adrenergic blocking drugs. Ann. N.Y. Acad. Sci., 139: 606 – 631.en_US
dc.identifier.citedreferenceBalcon, R., Jewitt, D. E., Davies, J. P. H., and Oram, S. ( 1967 ): A controlled trial of propranolol in acute myocardial infarction. Am. Heart J., 74: 582 – 584.en_US
dc.identifier.citedreferenceBarber, J. M., Boyle, D. McC., Chaturvedi, N. C., Singh, N., and Walsh, M. J. ( 1976 ): Practolol in acute myocardial infarction. Ada Medica Scand., 587 ( Suppl.): 213 – 219.en_US
dc.identifier.citedreferenceBarber, N. S., Evans, D. W., Howitt, G., Thomas, M., Wilson, C., Lewis, J. A., Dawes, P. M., Handler, K., and Tuson, R. ( 1980 ): Multicenter postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Br. Heart J., 44: 96 – 100.en_US
dc.identifier.citedreferenceBecker, L. C., Fortuin, N. J., and Pitt, B. ( 1971 ): Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ. Res., 28: 263 – 269.en_US
dc.identifier.citedreferenceBigger, J. T., Dresdale, R. J., Heissenbuttel, R. H., Weld, F. M., and Wit, A. L. ( 1977 ): Ventricular arrhythmias in ischemic heart disease: Mechanism, prevalence, significance and management. Prog. Cardiovasc. Dis., 19: 255 – 296.en_US
dc.identifier.citedreferenceBraunwald, E. ( 1971 ): Control of myocardial oxygen consumption: Physiologic and clinical considerations. Am. J. Cardiol., 27: 416 – 432.en_US
dc.identifier.citedreferenceDoyle, J. T. ( 1979 ): The risk of sudden death: The general population. Working group on Arteriosclerosis, NIH, Bethesda.en_US
dc.identifier.citedreferenceDresel, P. E., and Potter, P. ( 1978 ): The effect of propranolol and dimethylpropranoiol on cardiac conduction. Can. J. Physiol. Pharmacol., 57: 637 – 641.en_US
dc.identifier.citedreferenceDurrer, D., Van Lier, A. A. W., and Buller, J. ( 1964 ): Epicardial and intramural excitation in chronic myocardial infarction. Am. Heart J., 68 ), 675.en_US
dc.identifier.citedreferenceGibson, J. K., Burmeister, J. L., and Lucchesi, B. R. ( 1978 ): Electrophysiologic effects of UM-272 on myocardial ischemia in the canine heart. J. Pharmacol. Exp. Ther., 207: 304 – 310.en_US
dc.identifier.citedreferenceGibson, J. K., Korn, N. L., Counsell, R. E., and Lucchesi, B. R. ( 1979 ): Tissue distribution and antiarrhythmic action of N-dimethylpropranolol (UM-272) in the dog. Fed. Proc., 38 ), 697.en_US
dc.identifier.citedreferenceGibson, J. K., and Lucchesi, B. R. ( 1980 ): Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in post-infarction canine myocardium. J. Pharmacol. Exp. Ther., 214: 347 – 353.en_US
dc.identifier.citedreferenceGrant, R. P., and Murray, R. H. ( 1954 ): The QRS complex deformity of myocardial infarction in the human subject. Am. J. Med., 17 ), 587.en_US
dc.identifier.citedreferenceGross, G. J., Warltier, D. C., and Hardman, H. F. ( 1978 ): Beneficial actions of N-dimethyl propranolol on myocardial oxygen balance and transmural perfusion gradients distal to a severe coronary artery stenosis in the canine heart. Circulation, 58: 663 – 669.en_US
dc.identifier.citedreferenceGross, G. J., and Winbury, M. M. ( 1973 ): Beta adrenergic blockade on intramyocardial distribution of coronary blood flow. J. Pharmacol. Exp. Ther., 187: 451 – 464.en_US
dc.identifier.citedreferenceHarris, A. S. ( 1950 ): Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation, 1: 1318 – 1327.en_US
dc.identifier.citedreferenceHearse, D. J., Garlick, P. B., and Humphrey, S. M. ( 1977 ): Ischemic contracture of the myocardium: Mechanisms and prevention. Am. J. Cardiol., 39: 986 – 993.en_US
dc.identifier.citedreferenceHillis, L. D., Askenazi, J., Braunwald, E., Radvany, P., Muller, I. E., Fishbein, M. C., and Maroko, P. R. ( 1976 ): Uses of changes in epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion. Circulation, 54 ), 591.en_US
dc.identifier.citedreferenceHoffman, B. F., and Rosen, M. R. ( 1981 ): Cellular mechanisms for cardiac arrhythmias. Circ. Res., 49: 2 – 15.en_US
dc.identifier.citedreferenceHolman, B. L., de Wanjee, M. K., Idoine, J., Fliegel, C. P., Davis, M. D., Treves, S., and Eldh, P. ( 1973 ): Detection and localization of experimental myocardial infarction. J. Nucl. Med., 14: 595 – 599.en_US
dc.identifier.citedreferenceHorowitz, L. N., Josephson, M. E., Farshidi, A., Spielman, S. R., Michelson, E. L., and Greenspan, A. M. ( 1978 ): Recurrent sustained ventricular tachycardia. 3. Role of electrophysiologic study in selection of antiarrhythmic regimens. Circulation, 58: 986 – 998.en_US
dc.identifier.citedreferenceHorowitz, L. N., Josephson, M. E., and Kastor, J. A. ( 1980 ): Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog. Cardiovasc. Dis., 23: 81 – 98.en_US
dc.identifier.citedreferenceJosephson, M. E., Kastor, J. A., and Horowitz, L. N. ( 1980 ): Electrophysiologic management of recurrent ventricular tachycardia in acute and chronic ischemic heart disease. Cardiovasc. Clin., 11: 35 – 55.en_US
dc.identifier.citedreferenceKastor, J. A., Horowitz, L. N., Harken, A. H., and Josephson, M. E. ( 1981 ): Clinical electro-physiology of ventricular tachycardia. N. Engl. J. Med., 304: 1004 – 1020.en_US
dc.identifier.citedreferenceKatz, A. M., and Tada, M. ( 1977 ): The “stone heart” and other challenges to the biochemist. Am. J. Cardiol., 39: 1073 – 1077.en_US
dc.identifier.citedreferenceKjekshus, J. K., and Sobel, B. E. ( 1970 ): Depressed myocardial phosphokinase activity following experimental myocardial infarction in the rabbit. Circ. Res., 27 ), 403.en_US
dc.identifier.citedreferenceKniffen, F. J. ( 1973 ): The antiarrhythmic activity of quaternary ammonium compounds. Doctoral Dissertation, University of Michigan.en_US
dc.identifier.citedreferenceKniffen, F. J., Lomas, T. E., Burmeister, W. E., and Lucchesi, B. R. ( 1975 ): Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST-segment changes in the canine heart. J. Pharmacol. Exp. Ther., 194: 234 – 243.en_US
dc.identifier.citedreferenceKniffen, F. J., Lomas, T. E., and Lucchesi, B. R. ( 1974 ): Effects of dl-propranolol and dimethyl propranolol (UM-272) on ischemic ST-segment changes in the canine heart. Fed. Proc., 33 ), 389.en_US
dc.identifier.citedreferenceKniffen, F. J., Schuster, D. P., and Lucchesi, B. R. ( 1973 ): Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart. J. Pharmacol. Exp. Ther., 187: 260 – 268.en_US
dc.identifier.citedreferenceKu, D. D., and Lucchesi, B. R. ( 1978 ): Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion. Circulation, 57: 541 – 548.en_US
dc.identifier.citedreferenceLazzara, R., El-Sherif, N., Hope, R. R., and Scherlag, B. J. ( 1978 ): Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction. Circ. Res., 72: 740 – 749.en_US
dc.identifier.citedreferenceLevine, R. R., and Pelikan, E. W. ( 1961 ): The influence of experimental procedures and dose on the intestinal absorption of an onium compound, benzomethamine. J. Pharmacol. Exp. Ther., 131: 319 – 327.en_US
dc.identifier.citedreferenceLindstrom, T. D., Murphy, P. J., Smallwood, J. K., Wiest, S. A., and Steinberg, M. I. ( 1982 ): Correlation between the disposition of 14 C-clofilium and its cardiac electrophysiological effects. J. Pharmacol. Exp. Ther., 221: 584 – 589.en_US
dc.identifier.citedreferenceLucchesi, B. R., Burmeister, W. E., Lomas, T. E., and Abrams, G. D. ( 1976 ): Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). J. Pharmacol. Exp. Ther., 199: 310 – 328.en_US
dc.identifier.citedreferenceLucchesi, B. R., and Hardman, H. F. ( 1961 ): The influence of dichloroisoproterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin-induced cardiac arrhythmias. J. Pharmacol. Exp. Ther., 132: 372 – 381.en_US
dc.identifier.citedreferenceMalek, P., Kolc, J., Zastava, V., Zak, F., and Peleska, B. ( 1963 ): Fluorescence of tetracycline analogues fixed in myocardial infarction. Cardiologica (Basel), 42: 303 – 318.en_US
dc.identifier.citedreferenceMan, R. V., and Dresel, P. E. ( 1977 ): Effect of lidocaine and methyllidocaine on cardiac conduction. J. Pharmacol. Exp. Ther., 201: 184 – 191.en_US
dc.identifier.citedreferenceMaroko, P. R., and Braunwald, E. ( 1976 ): Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. Circulation, 53 ( Suppl. I ): 162 – 168.en_US
dc.identifier.citedreferenceMaroko, P. R., Kjekshus, J. K., Sobel, B. E., Watanabe, T., Covell, J. W., Ross, J., Jr, and Braunwald, E. ( 1971 ): Factors influencing infarct size following experimental coronary artery occlusion. Circulation, 43: 67 – 82.en_US
dc.identifier.citedreferenceMichelson, E. L., Naito, M., David, D., Dreifus, L. S., and Moore, E. N. ( 1981 ): Antiarrhythmic efficacy and electropharmacology of clofilium in a chronic canine ventricular tachycardia model. Circulation, 64 ), 124.en_US
dc.identifier.citedreferenceMichelson, E. L., Spear, J. F., and Moore, E. N. ( 1981 ): Effects of procainamide on strength-interval relations in normal and chronically infarcted canine myocardium. Am. J. Cardiol., 47: 1223 – 1232.en_US
dc.identifier.citedreference48. Multicentre International Study: Improvement in prognosis of myocardial infarction by long term beta-adrenoceptor blockade using practolol. Br. Med. J., 3 ( 5986 ): 735 – 740.en_US
dc.identifier.citedreference49. Multicentre International Study: Supplementary report: Reduction in mortality after myocardial infarction with long-term beta-adrenergic blockade. Br. Med. J., 2 ( 6084 ): 419 – 421.en_US
dc.identifier.citedreferenceMyerburg, R. J., Briese, F. W., Conde, C. A., Mallon, S. M., Liberthson, R. R., and Castellanos, A. ( 1979 ): Antiarrhythmic drug therapy in survivors of prehospital cardiac arrest. Comparison of effects on chronic ventricular arrhythmias and recurrent cardiac arrest. Circulation, 59: 855 – 865.en_US
dc.identifier.citedreferenceMyerburg, R. J., Kessler, K. M., Kiem, L., Pefkaros, K. C., Conde, C. A., Cooper, D., and Castellanos, A. ( 1981 ): Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of reentrant ventricular tachycardia. Circulation, 64: 280 – 290.en_US
dc.identifier.citedreferenceMyers, G. B., Klein, H. A., and Hiratzka, T. ( 1948 ): Correlation of electrocardiographic and pathologic findings in anteroposterior infarction. Am. Heart. J., 37 ), 205.en_US
dc.identifier.citedreferenceNamm, D. H., Wang, C. M., El-Sayad, S., Copp, F., and Maxwell, R. A. ( 1975 ): Effects of bretylium on rat cardiac muscle: The electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts. J. Pharmacol. Exp. Ther., 193: 194 – 207.en_US
dc.identifier.citedreferenceMorris, R. M., Caughey, D. E., and Scott, P. J. ( 1968 ): Trial of propranolol in acute myocardial infarction. Br. Med. J., 2 ( 5602 ): 398 – 400.en_US
dc.identifier.citedreference55. Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med., 304: 801 – 807.en_US
dc.identifier.citedreferenceOlson, R. E. ( 1969 ): Metabolic interventions in the treatment of infarcting myocardium. Circulation, 40 ( Suppl. 4 ): 195 – 201.en_US
dc.identifier.citedreferenceOlson, E. G., Goodyear, A. V. N., Langon, R. A., Cohen, L. S., and Wolfson, S. ( 1976 ): N-Dimethylisopropyl propranolol: Effects on myocardial oxygen demands. Circulation, 53: 501 – 505.en_US
dc.identifier.citedreferencePatterson, E., Gibson, J. K., and Lucchesi, B. R. ( 1980 ): Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. Am. J. Cardiol., 46: 792 – 799.en_US
dc.identifier.citedreferencePatterson, E., Stetson, P., and Lucchesi, B. R. ( 1980 ): Plasma and myocardial tissue concentrations of UM-272 (N, N-Dimethyl-propranolol) after oral administration in dogs. J. Pharmacol. Exp. Ther., 214: 449 – 453.en_US
dc.identifier.citedreferencePatterson, E., Gibson, J. K., and Lucchesi, B. R. ( 1981 ): Electrophysiologic actions of lidocaine in a canine model of chronic myocardial ischemic injury-arrhythmogenic actions of lidocaine. Circulation, 64 ), 123.en_US
dc.identifier.citedreferencePatterson, E., Holland, K., Eller, B., and Lucchesi, B. R. ( 1982 ): Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction—A conscious canine model of sudden coronary death. Am. J. Cardiol., 50: 1414 – 1423.en_US
dc.identifier.citedreferencePatterson, E., and Lucchesi, B. R. ( 1981 ): Chronic ventricular tachyarrhythmias in the conscious dog: Prevention by UM-272 (dimethylpropranolol). J. Cardiovasc. Pharmacol., 3: 769 – 780.en_US
dc.identifier.citedreferencePatterson, E., and Lucchesi, B. R. ( 1981 ): Antifibrillatory properties of nadolol—Lack of correlation between ventricular fibrillation threshold determinations and programmed electrical stimulation. Circulation, 64 ), 124.en_US
dc.identifier.citedreferencePeter, T., Hamamoto, H., Jordon, J., Platt, M., and Mandel, W. ( 1980 ): Indications for antiarrhythmic therapy as prophylaxis against sudden death. Cardiovasc. Clin., 11: 249 – 266.en_US
dc.identifier.citedreferenceReele, S., Woosley, D., Komhauser, D., Carr, K., and Shand, D. ( 1978 ): Antiarrhythmic efficacy of pranolium in man. Clin. Res., 26: 264A.en_US
dc.identifier.citedreferenceRomson, J. R., Haack, D. W., and Lucchesi, B. R. ( 1980 ): Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for in vivo evaluation of antithrombotic agents. Thromb. Res., 17: 841 – 853.en_US
dc.identifier.citedreferenceRosen, M. R., Miura, D. S., and Danilo, P. ( 1975 ): The effects of dimethyl quaternary propranolol on the electrophysiologic properties of canine cardiac Purkinje fibers. J. Pharmacol. Exp. Ther., 193: 209 – 217.en_US
dc.identifier.citedreferenceRuberman, W., Weinblatt, E., Goldberg, J. D., Frank, C. W., Chaudhary, B. S., and Shapiro, S. ( 1981 ): Ventricular premature complexes and sudden death after myocardial infarction. Circulation, 64: 297 – 305.en_US
dc.identifier.citedreferenceRyden, L., Berlin, A., and Freiber, L. R. ( 1975 ): Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound, QX-572, in man. Eur. J. Clin. Pharmacol., 8: 277 – 282.en_US
dc.identifier.citedreferenceRyden, L., Hjalmarson, A., Wasir, H., and WerkÖ, L. ( 1974 ): Effects of long acting antiarrhythmic agent, Astra QK-572, on refractory ventricular tachyarrhythmias. Br. Heart J., 36: 811 – 821.en_US
dc.identifier.citedreferenceSchuster, D. P., Lucchesi, B. R., Nobel, N. C., Mimnaugh, M. N., Counsell, R. E., and Kniffen, F. J. ( 1973 ): The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol. J. Pharmacol. Exp. Ther., 184: 213 – 227.en_US
dc.identifier.citedreferenceSchulze, R. A., Strauss, H. W., and Pitt, B. ( 1977 ): Sudden death in the year following myocardial infarction. Am. J. Med., 62: 192 – 199.en_US
dc.identifier.citedreferenceShell, W. E., Kjershus, J. K., and Sobel, B. E. ( 1971 ): Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase (CPK) activity. J. Clin. Invest., 50 ), 2614.en_US
dc.identifier.citedreferenceSnow, P. J. D. ( 1965 ): Effect of propranoloi in myocardial infarction. Lancet, 2: 551 – 553.en_US
dc.identifier.citedreferenceSobel, B. E., Roberts, R., and Larson, K. B., ( 1976 ): Estimation of infarct size from serum MB creatine phosphokinase activity: Applications and limitations. Am. J. Cardiol., 37 ), 474.en_US
dc.identifier.citedreferenceStephan, S. A. ( 1966 ): Unwanted effects of propranolol. Am. J. Cardiol., 18: 463 – 472.en_US
dc.identifier.citedreferenceSybers, H. O., Ashraf, M., Brauthwaite, J. R., and Lok, M. ( 1972 ): Early myocardial infarction. A fluorescent method of detection. Arch. Pathol., 93: 49 – 54.en_US
dc.identifier.citedreferenceTuraheim, K., and Lauterbach, F. O. ( 1977 ): Absorption and secretion of monoquaternary ammonium compounds by the isolated intestinal mucosa. Biochem. Pharmacol., 26: 99 – 108.en_US
dc.identifier.citedreferenceVan de Pol, C. J., Farshidi, A., Spielman, S. R., Greenspan, A. M., Horowitz, L. N., and Josephson, M. E. ( 1980 ): Incidence and clinical significance of induced ventricular tachycardia. Am. J. Cardiol., 45: 725 – 731.en_US
dc.identifier.citedreferenceVismara, L. A., Amsterdam, E., and Mason, D. T. ( 1975 ): Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge. Am. J. Med., 59: 6 – 12.en_US
dc.identifier.citedreferenceVogel, V. M., Romson, J. L., Bush, L. R., Shlafer, M., and Lucchesi, B. R. ( 1980 ): Protective effects of dimethylpropranolol (UM-272) during global ischemia of isolated feline hearts. J. Pharmacol. Exp. Ther., 212: 560 – 568.en_US
dc.identifier.citedreferenceWarltier, D. C., Gross, G. J., and Hardman, H. F. ( 1978 ): Effect of N-dimethyl propranolol on regional myocardial blood flow and oxygen consumption in the canine heart. J. Pharmacol. Exp. Ther., 204: 294 – 302.en_US
dc.identifier.citedreferenceWairen, S., Lucchesi, B., and Shlafer, M. ( 1979 ): Effects of N-dimethyl propranolol (UM-272) on isolated cardiac mitochondria and microsomes. Res. Commun. Chem. Pathol. Pharmacol., 25: 227 – 239.en_US
dc.identifier.citedreferenceWilcox, R. G., Roland, J. M., Banks, D. C., Hamptom, J. R., and Mitchell, J. R. A. ( 1980 ): Randomized trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br. Med. J., 280 ( 6218 ); 885 – 888.en_US
dc.identifier.citedreferenceWilcox, R. G., Rowley, J. M., Hampton, J. R., Mitchell, J. R. A., Roland, J. M., and Banks, D. C. ( 1980 ): Randomized placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet, 2 ( 8198 ): 765 – 769.en_US
dc.identifier.citedreferenceWilhelmsson, C., Vedin, J. A., Wilhelmsson, L., Tibblin, G., and Werko, L. ( 1974 ): Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet, 2 ( 7890 ), 1157 – 1159.en_US
dc.identifier.citedreferenceWolfson, S., Olson, E. G., Langon, R. A., Goodyear, A. V. N., and Cohen, L. S. ( 1974 ): N-Dimethylisopropyl propranolol (SC-27761), an analogue without beta-blocking or anesthetic actions: Effects on myocardial demands. Circulation, 50 ( Suppl. III ): 37.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1527-3466.1983.tb00447.x.pdf
Size:
4.258MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.